 Connection
Sara Price to Patient Reported Outcome Measures
This is a "connection" page, showing publications Sara Price has written about Patient Reported Outcome Measures.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.488 |
|
|
|
-
Salz T, Dressler EV, Kittel C, Salner A, Mayer DK, Nightingale CL, Hughes RT, Kriplani A, Atkinson TM, Patil S, Oeffinger KC, Price SN, Asad S, Sheedy J, Jinna S, Lesser G, Ostroff JS, Weaver KE. Impact of an Electronic Patient-Reported Outcome-Informed Clinical Decision Support Tool on Clinical Discussions With Head and Neck Cancer Survivors: Findings From the HN-STAR Randomized Controlled Trial (WF-1805CD). JCO Oncol Pract. 2025 Dec; 21(12):1786-1799.
Score: 0.166
-
Price SN, Willis AR, Hensley A, Hyson J, Sohl SJ, D'Agostino RB, Farris M, Petty WJ, de Hoyos A, Weaver KE, Wentworth S. Implementation and Retrospective Examination of a Lung Cancer Survivorship Clinic in a Comprehensive Cancer Center. Clin Lung Cancer. 2025 Jan; 26(1):e41-e54.
Score: 0.154
-
Price SN, Neil JM, Flores M, Ponzani C, Muzikansky A, Ballini L, Ostroff JS, Park ER. Patient-Reported Receipt of Oncology Clinician-Delivered Brief Tobacco Treatment (5As) Six Months following Cancer Diagnosis. Oncology. 2023; 101(5):328-342.
Score: 0.139
-
Ver Hoeve ES, Ali-Akbarian L, Price SN, Lothfi NM, Hamann HA. Patient-reported financial toxicity, quality of life, and health behaviors in insured US cancer survivors. Support Care Cancer. 2021 Jan; 29(1):349-358.
Score: 0.028
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|